Ignite Creation Date:
2024-05-06 @ 2:46 AM
Last Modification Date:
2024-10-26 @ 11:23 AM
Study NCT ID:
NCT02129075
Status:
COMPLETED
Last Update Posted:
2021-11-16
First Post:
2014-04-30
Brief Title:
A Vaccine CDX-1401 With or Without a Biologic Drug CDX-301 for the Treatment of Patients With Stage IIB-IV Melanoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cutaneous Melanoma |
| Melanoma |
| Melanoma of Unknown Primary |
| Mucosal Melanoma |
| Ocular Melanoma |
| Stage IIB Cutaneous Melanoma AJCC v6 and v7 |
| Stage IIC Cutaneous Melanoma AJCC v6 and v7 |
| Stage III Cutaneous Melanoma AJCC v7 |
| Stage IIIA Cutaneous Melanoma AJCC v7 |
| Stage IIIB Cutaneous Melanoma AJCC v7 |
| Stage IIIC Cutaneous Melanoma AJCC v7 |
| Stage IV Cutaneous Melanoma AJCC v6 and v7 |
Keywords: